Flavobacterium columnare (F. columnare)

Flavobacterium columnare is a Gram-negative, aerobic, rod-shaped bacterium that serves as the primary causative agent of columnaris disease in freshwater fish (Source: Wikipedia). This pathogen is characterized by its ability to cause significant mucosal damage, leading to skin lesions, fin rot, and gill necrosis, which often results in high mortality rates in aquaculture settings (Source: NIH, PubMed). The bacterium utilizes specialized mechanisms such as gliding motility and the secretion of degradative enzymes like chondroitin AC lyase to invade host tissues (Source: Journal of Fish Diseases). While it is an organism rather than a single molecular target, it is the focus of various antimicrobial therapies including oxytetracycline and florfenicol (Source: FDA). These treatments aim to inhibit bacterial growth by targeting essential prokaryotic processes like protein synthesis. However, the emergence of multi-drug resistant strains and the environmental impact of chemical treatments remain major challenges in managing this pathogen (Source: Frontiers in Microbiology).

Other names

Bacillus columnarisCytophaga columnarisFlexibacter columnarisColumnaris disease agent

Antibiotics targeting this bacterium typically act by inhibiting bacterial protein synthesis (e.g., tetracyclines, florfenicol) or interfering with metabolic pathways like folic acid synthesis (e.g., sulfonamides) (Source: Merck Veterinary Manual).